Clinical Trial

SUCCESS - Feasibility of HPV Testing and Treatment of Pre-cancerous Cervical Cancer Lesions (HPV Study)

Study acronym: HPV
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The goal is to assess the feasibility and acceptability of integrating into existing health systems, provision of HPV screening and treatment of pre-cancerous cervical cancer lesions with ablative treatments in Burkina Faso, Côte d'Ivoire, Guatemala, and the Philippines. Study findings will inform implementation of cervical cancer prevention and treatment services as part of a global effort to eliminate cervical cancer, with particular relevance for low-and-middle income countries. This will inform country strategy and guidelines on offering integrated cervical cancer prevention and treatment services in a manner that is culturally sensitive, client oriented, and system appropriate.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2021-11-15; most recent amendment 2025-09-11.
Status change: Recruiting → Active, Not Recruiting 2025-09-11
Status change: Not Yet Recruiting → Recruiting 2022-04-28
Trial Details
NCT Number NCT05133661
Lead Sponsor Jhpiego
Collaborators: UNITAID, Expertise France, World Health Organization
Conditions Cervical Cancer
Enrollment 17,602 participants
Start Date 2022-04-19
Primary Completion 2025-09-05 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-17